2024 Approvals
Letybo Approved as a New Therapy for Moderate to Severe Glabellar Lines
What is it prescribed for? LETYBO approved on February 29, 2024, is indicated to treat moderate-to-severe frown lines in adults. What is the name of the drug and what does it do? Letybo (pronounced leh-TEE-boh), (generic name: letibotulinumtoxinA-wlbg), is a medication indicated for the temporary improvement in the appearance of